Chronic-phase CML patients, those at high risk of blast crisis, frequently had HOXA5 hypermethylated, having more than 80% methylation of promoter CpG sites, and had HOXA4, found via the COBRA method and pyrosequencing. The gene discussed is HOXA4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.